Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01050504 : Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Patients with localized and/or metastatic bladder/urothelial or prostate cancer who
have disease in the primary organ, biopsy accessible bone metastases (collaborating
radiologists will determine if bone metastasis is appropriate for biopsy) or soft
tissue metastases are eligible; men and women without cancer are eligible to have
blood or normal tissue collected if acquired as part of non-research procedures (e.g.
transurethral resection of the prostate or bladder); in patients without malignancy,
no additional tissue beyond that necessary for care will be procured

- Ability to adequately understand and give informed consent

- Local or metastatic disease to soft tissue or bone at sites accessible to biopsy with
minimal risk of complications

- Platelet count > 50,000

- White blood cell (WBC) > 1,500

- Hemoglobin (Hgb) > 8.0

- International normalized ratio (INR) < 1.5

- Partial thromboplastin time (PTT) < 45

- No history of excessive unexplained bleeding from previous surgery

Exclusion Criteria:

- Patients unable to stop chronic anticoagulation with warfarin or Lovenox for less
than 3 days

- Serious or uncontrolled infection

- Treatment with a vascular endothelial growth factor (VEGF) inhibitor (such as
Avastin) within the past 28 days
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557